Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 11:13 AM ET | Feedback | Site Changes | Help
The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology.
View All Commentary (ITMN)
Recs
MrSandor (66.07) Submitted: 4/02/08 12:37 AM : Start Price: $17.39 ITMN Score: 8.59
Hot stock with lots of potential. By '09 if product gets approval, this stock could be trading above 100-150, delving this company into a multi-billion dollar profit margin within a few short years.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK